Collegium Pharmaceutical Inc
NASDAQ:COLL
Collegium Pharmaceutical Inc
NASDAQ:COLL
Price:
37.51 USD
Market Closed
Updated:
May 5, 2024
Collegium Pharmaceutical Inc
Net Income (Common)
|
Collegium Pharmaceutical Inc
Net Income (Common) Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
Net Income (Common)
$48.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Income (Common)
$38.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
21%
|
CAGR 10-Years
10%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Income (Common)
-$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Income (Common)
-$309m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Income (Common)
$2.3B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Income (Common)
$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
See Also
What is Collegium Pharmaceutical Inc's Net Income (Common)?
Net Income (Common)
48.2m
USD
48.2m
USD
Based on the financial report for Dec 31, 2023, Collegium Pharmaceutical Inc's Net Income (Common) amounts to 48.2m USD.
What is Collegium Pharmaceutical Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
22%
22%
The average annual Net Income (Common) growth rates for Collegium Pharmaceutical Inc have been 22% over the past three years .
You don't have any saved screeners yet
